Skip to main content
Top
Published in: memo - Magazine of European Medical Oncology 3/2020

01-09-2020 | Triage | editorial

Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?

Author: Prof. Semir Beslija, MD, PhD

Published in: memo - Magazine of European Medical Oncology | Issue 3/2020

Login to get access

Excerpt

The COVID-19 (coronavirus disease 19) pandemic has placed a major challenge on the healthcare systems globally requiring adaptations and reorganization of health services in a very short time. The lack of existing guidance for management of the disease forced hospitals to design new protocols and solutions on their own. While this represented a challenge, it also provided an opportunity to medical professionals to rethink the way we do healthcare. …
Footnotes
1
Clinical Center of Sarajevo University is the largest medical, research, and educational Institution in Bosnia and Herzegovina. It consists of 44 clinics, with over 3400 employees. The oncology division is comprised of medical and radiation oncology departments and an outpatient hospital. The clinic has 110 employees, and 80 hospital beds. Approximately 1,000,000 patients are covered by the clinic services.
 
Metadata
Title
Managing an oncology clinic during the COVID-19 pandemic—how we did it in Sarajevo?
Author
Prof. Semir Beslija, MD, PhD
Publication date
01-09-2020
Publisher
Springer Vienna
Keywords
Triage
COVID-19
Published in
memo - Magazine of European Medical Oncology / Issue 3/2020
Print ISSN: 1865-5041
Electronic ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-020-00643-8

Other articles of this Issue 3/2020

memo - Magazine of European Medical Oncology 3/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine